BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 013230
(447 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|2WB8|A Chain A, Crystal Structure Of Haspin Kinase
Length = 352
Score = 169 bits (427), Expect = 3e-42, Method: Compositional matrix adjust.
Identities = 105/295 (35%), Positives = 161/295 (54%), Gaps = 11/295 (3%)
Query: 139 KVGEGTFGEAF--LAGNT--VCKVVPIDGDLKVNGEAQKKSXXXXXXXXXSWTLNHLRRN 194
K+GEG FGE F +A +T K++ I+G VNG QK S L+ L
Sbjct: 43 KIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLL--- 99
Query: 195 EGDTLNACTTFVEMFEIKVCQGPYDAALIQAWEDWDDKHCSENDNPKEFPENQRYIVFVL 254
G+ N F+ + + QG Y L++AW+ ++ S ND P F ++Q +IV
Sbjct: 100 SGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEF 159
Query: 255 QHGGKDLESFV--LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLHWGNVLLSRNDSVTM 312
+ GG DLE L ++ A+S+L Q+TA LAVAEA+ FEHRDLHWGNVLL + +
Sbjct: 160 EFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKL 219
Query: 313 NFLLDGKQMFVRTFGLSVTIIDFTLSRINTGEDIFFLDLSQDPELFSGPKGDKQFDTYRK 372
++ L+GK + + GL V+IID+TLSR+ + F D+S D +LF+G GD QFD YR
Sbjct: 220 HYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG-DGDYQFDIYRL 278
Query: 373 MKKVTEDQWEGSFPKTNXXXXXXXXXXXXXKKTFDRSSKDERDLRSLKKRLDKYN 427
MKK ++W P +N + TF ++ + ++ +K+++ +++
Sbjct: 279 MKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTF-KTKCNTPAMKQIKRKIQEFH 332
>pdb|3DLZ|A Chain A, Crystal Structure Of Human Haspin In Complex With Amp
pdb|3E7V|A Chain A, Crystal Structure Of Human Haspin With A
Pyrazolo-Pyrimidine Ligand
pdb|3F2N|A Chain A, Crystal Structure Of Human Haspin With An
Imidazo-Pyridazine Ligand
pdb|3FMD|A Chain A, Crystal Structure Of Human Haspin With An Isoquinoline
Ligand
pdb|3IQ7|A Chain A, Crystal Structure Of Human Haspin In Complex With
5-Iodotubercidin
Length = 357
Score = 169 bits (427), Expect = 4e-42, Method: Compositional matrix adjust.
Identities = 105/295 (35%), Positives = 161/295 (54%), Gaps = 11/295 (3%)
Query: 139 KVGEGTFGEAF--LAGNT--VCKVVPIDGDLKVNGEAQKKSXXXXXXXXXSWTLNHLRRN 194
K+GEG FGE F +A +T K++ I+G VNG QK S L+ L
Sbjct: 48 KIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLL--- 104
Query: 195 EGDTLNACTTFVEMFEIKVCQGPYDAALIQAWEDWDDKHCSENDNPKEFPENQRYIVFVL 254
G+ N F+ + + QG Y L++AW+ ++ S ND P F ++Q +IV
Sbjct: 105 SGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEF 164
Query: 255 QHGGKDLESFV--LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLHWGNVLLSRNDSVTM 312
+ GG DLE L ++ A+S+L Q+TA LAVAEA+ FEHRDLHWGNVLL + +
Sbjct: 165 EFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKL 224
Query: 313 NFLLDGKQMFVRTFGLSVTIIDFTLSRINTGEDIFFLDLSQDPELFSGPKGDKQFDTYRK 372
++ L+GK + + GL V+IID+TLSR+ + F D+S D +LF+G GD QFD YR
Sbjct: 225 HYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG-DGDYQFDIYRL 283
Query: 373 MKKVTEDQWEGSFPKTNXXXXXXXXXXXXXKKTFDRSSKDERDLRSLKKRLDKYN 427
MKK ++W P +N + TF ++ + ++ +K+++ +++
Sbjct: 284 MKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTF-KTKCNTPAMKQIKRKIQEFH 337
>pdb|2VUW|A Chain A, Structure Of Human Haspin Kinase Domain
Length = 336
Score = 163 bits (413), Expect = 2e-40, Method: Compositional matrix adjust.
Identities = 101/257 (39%), Positives = 144/257 (56%), Gaps = 10/257 (3%)
Query: 139 KVGEGTFGEAF--LAGNT--VCKVVPIDGDLKVNGEAQKKSXXXXXXXXXSWTLNHLRRN 194
K+GEG FGE F +A +T K++ I+G VNG QK S L+ L
Sbjct: 27 KIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLL--- 83
Query: 195 EGDTLNACTTFVEMFEIKVCQGPYDAALIQAWEDWDDKHCSENDNPKEFPENQRYIVFVL 254
G+ N F+ + + QG Y L++AW+ ++ S ND P F ++Q +IV
Sbjct: 84 SGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEF 143
Query: 255 QHGGKDLESFV--LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLHWGNVLLSRNDSVTM 312
+ GG DLE L ++ A+S+L Q+TA LAVAEA+ FEHRDLHWGNVLL + +
Sbjct: 144 EFGGIDLEQXRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKL 203
Query: 313 NFLLDGKQMFVRTFGLSVTIIDFTLSRINTGEDIFFLDLSQDPELFSGPKGDKQFDTYRK 372
++ L+GK + + GL V+IID+TLSR+ + F D+S D +LF+G GD QFD YR
Sbjct: 204 HYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSXDEDLFTG-DGDYQFDIYRL 262
Query: 373 MKKVTEDQWEGSFPKTN 389
KK ++W P +N
Sbjct: 263 XKKENNNRWGEYHPYSN 279
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 57/225 (25%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF +H +DL++F+ + + +S L Q+ GLA + + HRDL
Sbjct: 73 ENKLYLVF--EHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 129
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 130 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 189
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 190 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 249
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDLIVDRP 446
K +D R L S D K SAK A+ PFF D+ P
Sbjct: 250 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 56/220 (25%), Positives = 91/220 (41%), Gaps = 26/220 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF +H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 77 ENKLYLVF--EHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 133
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 134 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 193
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 194 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 253
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDL 441
K +D R L S D K SAK A+ PFF D+
Sbjct: 254 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 26/225 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL++F+ + + +S L Q+ GLA + + HRDL
Sbjct: 77 ENKLYLVFEFLH--QDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 133
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 134 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 193
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 194 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 253
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDLIVDRP 446
K +D R L S D K SAK A+ PFF D+ P
Sbjct: 254 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 298
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 26/225 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 81 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 137
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 138 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 197
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 198 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 257
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDLIVDRP 446
K +D R L S D K SAK A+ PFF D+ P
Sbjct: 258 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 302
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 26/225 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 78 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 134
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 135 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 194
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 195 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 254
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDLIVDRP 446
K +D R L S D K SAK A+ PFF D+ P
Sbjct: 255 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 299
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 26/225 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 76 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 132
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 133 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 192
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 193 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 252
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDLIVDRP 446
K +D R L S D K SAK A+ PFF D+ P
Sbjct: 253 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 297
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 26/225 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 77 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 133
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 134 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 193
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 194 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 253
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDLIVDRP 446
K +D R L S D K SAK A+ PFF D+ P
Sbjct: 254 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 298
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 26/220 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 78 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 134
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 135 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 194
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 195 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 254
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDL 441
K +D R L S D K SAK A+ PFF D+
Sbjct: 255 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 294
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 26/225 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 73 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 129
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 130 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 189
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 190 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 249
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDLIVDRP 446
K +D R L S D K SAK A+ PFF D+ P
Sbjct: 250 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 26/225 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 75 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 131
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 132 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 191
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 192 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 251
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDLIVDRP 446
K +D R L S D K SAK A+ PFF D+ P
Sbjct: 252 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 296
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 26/220 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 77 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 133
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 134 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 193
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 194 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 253
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDL 441
K +D R L S D K SAK A+ PFF D+
Sbjct: 254 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 26/220 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 76 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 132
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 133 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 192
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 193 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 252
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDL 441
K +D R L S D K SAK A+ PFF D+
Sbjct: 253 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 26/225 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 75 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 131
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 132 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 191
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 192 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 251
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDLIVDRP 446
K +D R L S D K SAK A+ PFF D+ P
Sbjct: 252 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 296
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 26/225 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 76 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 132
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 133 PENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 192
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 193 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 252
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDLIVDRP 446
K +D R L S D K SAK A+ PFF D+ P
Sbjct: 253 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 297
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 26/220 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 74 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 130
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 131 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 190
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 191 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 250
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDL 441
K +D R L S D K SAK A+ PFF D+
Sbjct: 251 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 26/225 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 74 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 130
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 131 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 190
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 191 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 250
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDLIVDRP 446
K +D R L S D K SAK A+ PFF D+ P
Sbjct: 251 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 295
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 26/220 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 73 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 129
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 130 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 189
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 190 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 249
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDL 441
K +D R L S D K SAK A+ PFF D+
Sbjct: 250 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 26/225 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 74 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 130
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 131 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 190
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 191 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 250
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDLIVDRP 446
K +D R L S D K SAK A+ PFF D+ P
Sbjct: 251 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 295
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 26/225 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 75 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 131
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 132 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 191
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 192 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 251
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDLIVDRP 446
K +D R L S D K SAK A+ PFF D+ P
Sbjct: 252 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 296
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 26/225 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 74 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 130
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 131 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 190
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 191 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 250
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDLIVDRP 446
K +D R L S D K SAK A+ PFF D+ P
Sbjct: 251 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 295
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 26/225 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 73 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 129
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 130 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 189
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 190 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 249
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDLIVDRP 446
K +D R L S D K SAK A+ PFF D+ P
Sbjct: 250 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 26/225 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 74 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 130
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 131 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 190
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 191 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 250
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDLIVDRP 446
K +D R L S D K SAK A+ PFF D+ P
Sbjct: 251 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 295
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 26/225 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 81 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 137
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 138 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSL 197
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 198 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 257
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDLIVDRP 446
K +D R L S D K SAK A+ PFF D+ P
Sbjct: 258 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 302
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 26/225 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 73 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 129
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 130 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 189
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 190 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 249
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDLIVDRP 446
K +D R L S D K SAK A+ PFF D+ P
Sbjct: 250 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 26/225 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 75 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 131
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 132 PENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 191
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 192 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 251
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDLIVDRP 446
K +D R L S D K SAK A+ PFF D+ P
Sbjct: 252 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 296
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 26/220 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 74 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 130
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 131 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 190
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 191 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 250
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDL 441
K +D R L S D K SAK A+ PFF D+
Sbjct: 251 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 26/220 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 73 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 129
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 130 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 189
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 190 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 249
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDL 441
K +D R L S D K SAK A+ PFF D+
Sbjct: 250 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 56/219 (25%), Positives = 89/219 (40%), Gaps = 26/219 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 74 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 130
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 131 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 190
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 191 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 250
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSD 440
K +D R L S D K SAK A+ PFF D
Sbjct: 251 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 26/220 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 74 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 130
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 131 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSL 190
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 191 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 250
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDL 441
K +D R L S D K SAK A+ PFF D+
Sbjct: 251 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 26/220 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 74 ENKLYLVFEFLH--QDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 130
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 131 PENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 190
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 191 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 250
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDL 441
K +D R L S D K SAK A+ PFF D+
Sbjct: 251 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 37.7 bits (86), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 56/225 (24%), Positives = 91/225 (40%), Gaps = 26/225 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF H +DL+ F+ + + +S L Q+ GL+ + + HRDL
Sbjct: 74 ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS-HRVLHRDLK 130
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 131 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 190
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 191 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 250
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDLIVDRP 446
K +D R L S D K SAK A+ PFF D+ P
Sbjct: 251 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 295
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 35.8 bits (81), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 55/220 (25%), Positives = 89/220 (40%), Gaps = 26/220 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF + DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 77 ENKLYLVF--EFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 133
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 134 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 193
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 194 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 253
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDL 441
K +D R L S D K SAK A+ PFF D+
Sbjct: 254 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 35.8 bits (81), Expect = 0.049, Method: Compositional matrix adjust.
Identities = 56/225 (24%), Positives = 90/225 (40%), Gaps = 26/225 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF + DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 77 ENKLYLVF--EFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 133
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 134 PENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 193
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 194 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 253
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDLIVDRP 446
K +D R L S D K SAK A+ PFF D+ P
Sbjct: 254 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 298
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 35.8 bits (81), Expect = 0.054, Method: Compositional matrix adjust.
Identities = 56/225 (24%), Positives = 90/225 (40%), Gaps = 26/225 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF + DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 75 ENKLYLVF--EFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 131
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 132 PENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 191
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 192 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 251
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDLIVDRP 446
K +D R L S D K SAK A+ PFF D+ P
Sbjct: 252 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 296
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 35.8 bits (81), Expect = 0.054, Method: Compositional matrix adjust.
Identities = 55/220 (25%), Positives = 89/220 (40%), Gaps = 26/220 (11%)
Query: 245 ENQRYIVFVLQHGGKDLESFV------LLNINEARSLLVQVTAGLAVAEAAYEFEHRDLH 298
EN+ Y+VF + DL+ F+ + + +S L Q+ GLA + + HRDL
Sbjct: 76 ENKLYLVF--EFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLK 132
Query: 299 WGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLSVTIIDFTLSRI-------NTGEDIF-- 347
N+L++ ++ + +F L + VRT+ V + + I +T DI+
Sbjct: 133 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 192
Query: 348 ---FLDLSQDPELFSG-PKGDKQFDTYRKMKKVTEDQWEGSFPKTNXXXXXXXXXXXXXK 403
F ++ LF G + D+ F +R + E W G +
Sbjct: 193 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 252
Query: 404 KTFDRSSKDERDLRSLKKRLD--KYNSAKEAIFDPFFSDL 441
K +D R L S D K SAK A+ PFF D+
Sbjct: 253 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 35.0 bits (79), Expect = 0.096, Method: Compositional matrix adjust.
Identities = 27/107 (25%), Positives = 52/107 (48%), Gaps = 15/107 (14%)
Query: 218 YDAALIQAWEDWDDKHCSENDNPK-----EFPENQRYIVFVLQ--HGGKDLESFVLLNI- 269
Y A ++Q ++ HC + +P + E+ Y+ VL+ H G ++ ++ +
Sbjct: 50 YKAGMVQRVQNEVKIHC-QLKHPSILELYNYFEDSNYVYLVLEMCHNG-EMNRYLKNRVK 107
Query: 270 ----NEARSLLVQVTAGLAVAEAAYEFEHRDLHWGNVLLSRNDSVTM 312
NEAR + Q+ G+ + + HRDL N+LL+RN ++ +
Sbjct: 108 PFSENEARHFMHQIITGMLYLHS-HGILHRDLTLSNLLLTRNMNIKI 153
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 33.1 bits (74), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 45/188 (23%), Positives = 72/188 (38%), Gaps = 19/188 (10%)
Query: 272 ARSLLVQVTAGLAVAEAAYEFEHRDLHWGNVLLSRNDSVTM-NF-LLDGKQMFVRTFGLS 329
+S L Q+ GL + HRDL N+L++RN + + NF L + VR +
Sbjct: 103 VKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161
Query: 330 VTIIDFTLSRINTGEDIF------------FLDLSQDPE-LFSGPKGDKQFD-TYRKMKK 375
V + + + G ++ F +L+ LF G D Q +R +
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221
Query: 376 VTEDQWEGSFPKTNXXXXXXXXXXXXXKKTFDRSSKDERDLRS--LKKRLDKYNSAKEAI 433
TE+QW + + + RDL LK + SA+EA+
Sbjct: 222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281
Query: 434 FDPFFSDL 441
P+FSD
Sbjct: 282 QHPYFSDF 289
>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs
Resolution)
Length = 362
Score = 31.6 bits (70), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 15/48 (31%), Positives = 27/48 (56%), Gaps = 1/48 (2%)
Query: 265 VLLNINEARSLLVQVTAGLAVAEAAYEFEHRDLHWGNVLLSRNDSVTM 312
++++ + + + GL V A HRDLH GN+LL+ N+ +T+
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLADNNDITI 175
>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With
Sb203580
Length = 362
Score = 31.2 bits (69), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 15/48 (31%), Positives = 27/48 (56%), Gaps = 1/48 (2%)
Query: 265 VLLNINEARSLLVQVTAGLAVAEAAYEFEHRDLHWGNVLLSRNDSVTM 312
++++ + + + GL V A HRDLH GN+LL+ N+ +T+
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLADNNDITI 175
>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The
Kinase Domain Of Focal Adhesion Kinase With A
Phosphorylated Activation Loop
Length = 276
Score = 30.4 bits (67), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 18/105 (17%)
Query: 245 ENQRYIVFVLQHGGKDLESFVLL---NINEARSLLV--QVTAGLAVAEAAYEFEHRDLHW 299
EN +I+ L G +L SF+ + +++ A +L Q++ LA E+ F HRD+
Sbjct: 82 ENPVWIIMELCTLG-ELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK-RFVHRDIAA 139
Query: 300 GNVLLSRNDSVTMNFLLDGKQMFVRTFGLSVTIIDFTLSRINTGE 344
NVL+S ND V + FGLS + D T + + G+
Sbjct: 140 RNVLVSSNDCVKLG-----------DFGLSRYMEDSTXXKASKGK 173
>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A
Methanesulfonamide Diaminopyrimidine Inhibitor
Length = 276
Score = 30.0 bits (66), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 18/105 (17%)
Query: 245 ENQRYIVFVLQHGGKDLESFVLL---NINEARSLLV--QVTAGLAVAEAAYEFEHRDLHW 299
EN +I+ L G +L SF+ + +++ A +L Q++ LA E+ F HRD+
Sbjct: 79 ENPVWIIMELCTLG-ELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAA 136
Query: 300 GNVLLSRNDSVTMNFLLDGKQMFVRTFGLSVTIIDFTLSRINTGE 344
NVL+S ND V + FGLS + D T + + G+
Sbjct: 137 RNVLVSSNDCVKLG-----------DFGLSRYMEDSTYYKASKGK 170
>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
pdb|3PXK|B Chain B, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
Length = 282
Score = 30.0 bits (66), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 18/105 (17%)
Query: 245 ENQRYIVFVLQHGGKDLESFVLL---NINEARSLLV--QVTAGLAVAEAAYEFEHRDLHW 299
EN +I+ L G +L SF+ + +++ A +L Q++ LA E+ F HRD+
Sbjct: 85 ENPVWIIMELCTLG-ELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAA 142
Query: 300 GNVLLSRNDSVTMNFLLDGKQMFVRTFGLSVTIIDFTLSRINTGE 344
NVL+S ND V + FGLS + D T + + G+
Sbjct: 143 RNVLVSSNDCVKLG-----------DFGLSRYMEDSTYYKASKGK 176
>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And
Kinase Domains Of Focal Adhesion Kinase.
pdb|2JKQ|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 30.0 bits (66), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 18/105 (17%)
Query: 245 ENQRYIVFVLQHGGKDLESFVLL---NINEARSLLV--QVTAGLAVAEAAYEFEHRDLHW 299
EN +I+ L G +L SF+ + +++ A +L Q++ LA E+ F HRD+
Sbjct: 82 ENPVWIIMELCTLG-ELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAA 139
Query: 300 GNVLLSRNDSVTMNFLLDGKQMFVRTFGLSVTIIDFTLSRINTGE 344
NVL+S ND V + FGLS + D T + + G+
Sbjct: 140 RNVLVSSNDCVKLG-----------DFGLSRYMEDSTYYKASKGK 173
>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 30.0 bits (66), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 18/105 (17%)
Query: 245 ENQRYIVFVLQHGGKDLESFVLL---NINEARSLLV--QVTAGLAVAEAAYEFEHRDLHW 299
EN +I+ L G +L SF+ + +++ A +L Q++ LA E+ F HRD+
Sbjct: 82 ENPVWIIMELCTLG-ELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAA 139
Query: 300 GNVLLSRNDSVTMNFLLDGKQMFVRTFGLSVTIIDFTLSRINTGE 344
NVL+S ND V + FGLS + D T + + G+
Sbjct: 140 RNVLVSSNDCVKLG-----------DFGLSRYMEDSTYYKASKGK 173
>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 30.0 bits (66), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 18/105 (17%)
Query: 245 ENQRYIVFVLQHGGKDLESFVLL---NINEARSLLV--QVTAGLAVAEAAYEFEHRDLHW 299
EN +I+ L G +L SF+ + +++ A +L Q++ LA E+ F HRD+
Sbjct: 462 ENPVWIIMELCTLG-ELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK-RFVHRDIAA 519
Query: 300 GNVLLSRNDSVTMNFLLDGKQMFVRTFGLSVTIIDFTLSRINTGE 344
NVL+S ND V + FGLS + D T + + G+
Sbjct: 520 RNVLVSSNDCVKLG-----------DFGLSRYMEDSTYYKASKGK 553
>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2ETM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2IJM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
pdb|2IJM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
Length = 281
Score = 30.0 bits (66), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 18/105 (17%)
Query: 245 ENQRYIVFVLQHGGKDLESFVLL---NINEARSLLV--QVTAGLAVAEAAYEFEHRDLHW 299
EN +I+ L G +L SF+ + +++ A +L Q++ LA E+ F HRD+
Sbjct: 84 ENPVWIIMELCTLG-ELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAA 141
Query: 300 GNVLLSRNDSVTMNFLLDGKQMFVRTFGLSVTIIDFTLSRINTGE 344
NVL+S ND V + FGLS + D T + + G+
Sbjct: 142 RNVLVSSNDCVKLG-----------DFGLSRYMEDSTYYKASKGK 175
>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak)
pdb|4I4F|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With An Allosteric Binding Pyrazolobenzothiazine
Compound
Length = 281
Score = 30.0 bits (66), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 18/105 (17%)
Query: 245 ENQRYIVFVLQHGGKDLESFVLL---NINEARSLLV--QVTAGLAVAEAAYEFEHRDLHW 299
EN +I+ L G +L SF+ + +++ A +L Q++ LA E+ F HRD+
Sbjct: 87 ENPVWIIMELCTLG-ELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAA 144
Query: 300 GNVLLSRNDSVTMNFLLDGKQMFVRTFGLSVTIIDFTLSRINTGE 344
NVL+S ND V + FGLS + D T + + G+
Sbjct: 145 RNVLVSSNDCVKLG-----------DFGLSRYMEDSTYYKASKGK 178
>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
pdb|4EBV|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
Length = 304
Score = 30.0 bits (66), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 18/105 (17%)
Query: 245 ENQRYIVFVLQHGGKDLESFVLL---NINEARSLLV--QVTAGLAVAEAAYEFEHRDLHW 299
EN +I+ L G +L SF+ + +++ A +L Q++ LA E+ F HRD+
Sbjct: 110 ENPVWIIMELCTLG-ELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAA 167
Query: 300 GNVLLSRNDSVTMNFLLDGKQMFVRTFGLSVTIIDFTLSRINTGE 344
NVL+S ND V + FGLS + D T + + G+
Sbjct: 168 RNVLVSSNDCVKLG-----------DFGLSRYMEDSTYYKASKGK 201
>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|A Chain A, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
Length = 373
Score = 28.9 bits (63), Expect = 6.4, Method: Compositional matrix adjust.
Identities = 14/26 (53%), Positives = 17/26 (65%), Gaps = 3/26 (11%)
Query: 126 DLFSKYSDPENIVKVGEGTFGEAFLA 151
D SKY E + K+G+GTFGE F A
Sbjct: 15 DEVSKY---EKLAKIGQGTFGEVFKA 37
>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 351
Score = 28.5 bits (62), Expect = 6.9, Method: Compositional matrix adjust.
Identities = 14/26 (53%), Positives = 17/26 (65%), Gaps = 3/26 (11%)
Query: 126 DLFSKYSDPENIVKVGEGTFGEAFLA 151
D SKY E + K+G+GTFGE F A
Sbjct: 14 DEVSKY---EKLAKIGQGTFGEVFKA 36
>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 28.5 bits (62), Expect = 7.0, Method: Compositional matrix adjust.
Identities = 14/26 (53%), Positives = 17/26 (65%), Gaps = 3/26 (11%)
Query: 126 DLFSKYSDPENIVKVGEGTFGEAFLA 151
D SKY E + K+G+GTFGE F A
Sbjct: 15 DEVSKY---EKLAKIGQGTFGEVFKA 37
>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|A Chain A, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|A Chain A, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNH|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|A Chain A, Structure Of Cdk9CYCLIN T F241L
pdb|4BCH|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 28.5 bits (62), Expect = 7.2, Method: Compositional matrix adjust.
Identities = 14/26 (53%), Positives = 17/26 (65%), Gaps = 3/26 (11%)
Query: 126 DLFSKYSDPENIVKVGEGTFGEAFLA 151
D SKY E + K+G+GTFGE F A
Sbjct: 15 DEVSKY---EKLAKIGQGTFGEVFKA 37
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.316 0.133 0.393
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 12,585,957
Number of Sequences: 62578
Number of extensions: 481207
Number of successful extensions: 1215
Number of sequences better than 100.0: 55
Number of HSP's better than 100.0 without gapping: 5
Number of HSP's successfully gapped in prelim test: 50
Number of HSP's that attempted gapping in prelim test: 1200
Number of HSP's gapped (non-prelim): 91
length of query: 447
length of database: 14,973,337
effective HSP length: 102
effective length of query: 345
effective length of database: 8,590,381
effective search space: 2963681445
effective search space used: 2963681445
T: 11
A: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.6 bits)
S2: 53 (25.0 bits)